Total Payments
$135,999
2024 Payments
$3,158
Companies
31
Transactions
398
Medicare Patients
182
Medicare Billing
$36,359
Payment Breakdown by Category
Other$102,260 (75.2%)
Travel$19,057 (14.0%)
Consulting$6,500 (4.8%)
Food & Beverage$6,250 (4.6%)
Research$1,917 (1.4%)
Education$14.91 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $101,760 | 50 | 74.8% |
| Travel and Lodging | $19,057 | 112 | 14.0% |
| Consulting Fee | $6,500 | 2 | 4.8% |
| Food and Beverage | $6,250 | 230 | 4.6% |
| Unspecified | $1,917 | 1 | 1.4% |
| Honoraria | $500.00 | 1 | 0.4% |
| Education | $14.91 | 2 | 0.0% |
Payments by Type
General
$134,082
397 transactions
Research
$1,917
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alkermes, Inc. | $118,443 | 212 | $0 (2024) |
| US WorldMeds, LLC | $13,379 | 35 | $0 (2020) |
| Indivior Inc. | $2,681 | 44 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $203.33 | 19 | $0 (2019) |
| Novo Nordisk Inc | $149.13 | 10 | $0 (2024) |
| ABBVIE INC. | $133.30 | 9 | $0 (2022) |
| PFIZER INC. | $103.24 | 7 | $0 (2021) |
| Braeburn Inc. | $93.96 | 5 | $0 (2024) |
| IDORSIA PHARMACEUTICALS US INC | $70.17 | 4 | $0 (2023) |
| Kaleo, Inc. | $69.01 | 5 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,158 | 22 | Indivior Inc. ($2,193) |
| 2023 | $5,763 | 24 | Alkermes, Inc. ($5,574) |
| 2022 | $17,146 | 33 | Alkermes, Inc. ($16,962) |
| 2021 | $17,055 | 42 | Alkermes, Inc. ($16,808) |
| 2020 | $10,818 | 35 | Alkermes, Inc. ($10,144) |
| 2019 | $36,463 | 82 | Alkermes, Inc. ($34,953) |
| 2018 | $26,278 | 83 | Alkermes, Inc. ($18,880) |
| 2017 | $19,319 | 77 | Alkermes, Inc. ($14,251) |
All Payment Transactions
398 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $38.00 | General |
| Category: OUD | ||||||
| 11/13/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: OUD | ||||||
| 10/16/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $35.72 | General |
| Category: OUD | ||||||
| 09/16/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $29.56 | General |
| Category: OUD | ||||||
| 09/09/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $26.52 | General |
| Category: Opioid Use Disorder | ||||||
| 08/29/2024 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $28.93 | General |
| Category: CNS | ||||||
| 08/21/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $22.26 | General |
| Category: OUD | ||||||
| 07/22/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $21.81 | General |
| Category: OUD | ||||||
| 07/03/2024 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: CNS | ||||||
| 06/27/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $21.17 | General |
| Category: Opioid Use Disorder | ||||||
| 06/24/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $22.49 | General |
| Category: OUD | ||||||
| 05/31/2024 | Indivior Inc. | — | — | Cash or cash equivalent | $1,916.91 | Research |
| Study: A PHASE II DOUBLE BLIND, PLACEBO CONTROLLED, RANDOMISED, DOSE-RANGING STUDY TO ASSESS THE SAFETY AND EFFICACY OF INDV-2000 OVER 3 MONTHS IN TREATMENT SEEKING INDIVIDUALS WITH OPIOID USE DISORDER | ||||||
| 05/13/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: OUD | ||||||
| 05/13/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $4.33 | General |
| Category: OUD | ||||||
| 04/18/2024 | Alkermes, Inc. | Vivitrol (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $800.00 | General |
| Category: CNS | ||||||
| 04/11/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: Diabetes | ||||||
| 04/08/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $25.01 | General |
| Category: OUD | ||||||
| 03/20/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: Opioid Use Disorder | ||||||
| 03/11/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: OUD | ||||||
| 02/15/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $23.54 | General |
| Category: OUD | ||||||
| 01/25/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: Opioid Use Disorder | ||||||
| 01/11/2024 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $22.46 | General |
| Category: CNS | ||||||
| 12/06/2023 | Alkermes, Inc. | Vivitrol (Drug) | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: CNS | ||||||
| 11/28/2023 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: Opioid Use Disorder | ||||||
| 11/20/2023 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: OUD | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A PHASE II DOUBLE BLIND, PLACEBO CONTROLLED, RANDOMISED, DOSE-RANGING STUDY TO ASSESS THE SAFETY AND EFFICACY OF INDV-2000 OVER 3 MONTHS IN TREATMENT SEEKING INDIVIDUALS WITH OPIOID USE DISORDER | Indivior Inc. | $1,917 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 47 | 157 | $27,258 | $10,363 |
| 2022 | 3 | 60 | 159 | $29,418 | $12,123 |
| 2021 | 2 | 44 | 114 | $21,084 | $8,968 |
| 2020 | 2 | 31 | 92 | $14,832 | $4,905 |
Total Patients
182
Total Services
522
Medicare Billing
$36,359
Procedure Codes
9
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 30 | 73 | $15,330 | $5,425 | 35.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 17 | 84 | $11,928 | $4,939 | 41.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 31 | 87 | $18,270 | $6,944 | 38.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 18 | 61 | $8,662 | $3,796 | 43.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 11 | 11 | $2,486 | $1,383 | 55.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 29 | 72 | $15,120 | $6,243 | 41.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 15 | 42 | $5,964 | $2,725 | 45.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 15 | 66 | $9,372 | $3,098 | 33.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 16 | 26 | $5,460 | $1,807 | 33.1% |
About Scott Erickson
Scott Erickson is a Family Medicine healthcare provider based in Bountiful, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/05/2005. The National Provider Identifier (NPI) number assigned to this provider is 1780681775.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Scott Erickson has received a total of $135,999 in payments from pharmaceutical and medical device companies, with $3,158 received in 2024. These payments were reported across 398 transactions from 31 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($101,760).
As a Medicare-enrolled provider, Erickson has provided services to 182 Medicare beneficiaries, totaling 522 services with total Medicare billing of $36,359. Data is available for 4 years (2020–2023), covering 9 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Bountiful, UT
- Active Since 07/05/2005
- Last Updated 03/21/2014
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1780681775
Products in Payments
- VIVITROL (Drug) $68,781
- Vivitrol 380 mg (Drug) $33,131
- Vivitrol (Drug) $16,531
- Lucemyra/Lofexidine (Drug) $8,275
- SUBLOCADE (Drug) $681.36
- XIFAXAN (Drug) $131.42
- VRAYLAR (Drug) $95.77
- BRIXADI (Drug) $93.96
- QUVIVIQ (Drug) $70.17
- SUBOXONE SUBLINGUAL FILM (Drug) $67.93
- Probuphine (Drug) $67.59
- Victoza (Drug) $58.39
- ELIQUIS (Drug) $55.44
- LUCEMYRA (Drug) $53.61
- JARDIANCE (Drug) $52.97
- Movantik (Drug) $52.15
- Prolia (Biological) $48.22
- Zubsolv (Drug) $47.00
- Ozempic (Drug) $43.14
- Dayvigo (Drug) $41.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Bountiful
Allen Freestone, Md, MD
Family Medicine — Payments: $9,138
Family Medicine $9,138
David Cope, Md, MD
Family Medicine — Payments: $6,614
Family Medicine $6,614
William Draper, Do, DO
Family Medicine — Payments: $5,187
Family Medicine $5,187
Dr. Antonina Callahan, Md, MD
Family Medicine — Payments: $4,441
Family Medicine $4,441
Dr. Brian Rodgers, D. O, D. O
Family Medicine — Payments: $4,368
Family Medicine $4,368
Allison Hanna, D.o, D.O
Family Medicine — Payments: $2,662
Family Medicine $2,662